Why is use of robot-assisted surgery for rectal cancer growing despite evidence it doesn’t offer significant advantages? Cleveland Clinic Florida Colorectal Chairman Steven Wexner, MD, discusses in our “Viewpoints” series.
Should colonoscopic tattooing be standard to improve the accuracy of intraoperative lesion localization? Cleveland Clinic Florida Colorectal Chairman Steven Wexner, MD, examines the evidence in our “Viewpoints” series.
Carol Burke, MD, and Co-investigator David Dornblaser, MS, share their findings with other physicians and digestive specialists at DDW 2017.
Cleveland Clinic Liver Tumor Clinic’s Federico Aucejo, MD, discusses how a regional-directed chemotherapy option is providing hope for patients with non-resectable colorectal cancer with liver metastases.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Gastroenterologist and ACG President Carol Burke, MD, explains how an online colorectal cancer risk assessment tool developed at Cleveland Clinic can help physicians get an important discussion underway.
A new study is the first using multigene panel testing to examine potentially important mutations among patients with early-onset colorectal cancer. Here’s how it suggests screening should change.
While it is still early in the evolution of transanal total mesorectal excision (TaTME), the technique is gaining traction as the go-to procedure in select cases, Cleveland Clinic colorectal surgeons report.
A recent survey of trainee colonoscopists and their primary care peers showed they have poor recollection of colorectal cancer screening and surveillance guidelines, despite having recently studied them.
Until now, there has been no specific clinical sign that a person has the colorectal cancer predisposition syndrome called MYH-associated polyposis (MAP). Dr. James Church explains his findings.
As a GI, how do you make sound judgments to balance cancer prevention and quality of life in patients with inherited colorectal cancer predisposition syndromes? Here Dr. James Church explains Cleveland Clinic’s approach.